Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 mg/ML
RxNorm 1601398
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1601398 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 mg/ML.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDCPrescribable
Semantic Clinical Drug Component (SCDC):
Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 mg/ML
(Atom ID: 6827956)
Patient Education
Serogroup B Meningococcal Vaccine (MenB)
Why get vaccinated? Meningococcal disease is a serious illness caused by a type of bacteria called Neisseria meningitidis. It can lead to meningitis (infection of the lining of the brain and spinal cord) and infections of the blood. Meningococcal disease often occurs without warning - even among people who are otherwise healthy. Meningococcal disease can spread from person to person through close contact (coughing or kissing) or lengthy contact, especially among people living in the same household. There are at least 12 types of Neisseria meningitidis, called ''serogroups.'' Serogroups A, B, C, W, and Y cause most meningococcal disease. Anyone can get meningococcal disease but certain people are at increased risk, including: Infants younger than one year old Adolescents and young adults 16 through 23 years old People with certain medical conditions that affect the immune system Microbiologists who routinely work with isolates of N. meningitidis People at risk because of an outbreak in their community Even when it is treated, meningococcal disease kills 10 to 15 infected people out of 100. And of those who survive, about 10 to 20 out of every 100 will suffer disabilities such as hearing loss, brain damage, amputations, nervous system problems, or severe scars from skin grafts. Serogroup B meningococcal (MenB) vaccines can help prevent meningococcal disease caused by serogroup B. Other meningococcal vaccines are recommended to help protect against serogroups A, C, W, and Y.
[Learn More]
* Please review the disclaimer below.
